Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Weiss

Showing results (231-240 of 244) with videos related to

Pageof 25
Sort By:
Human Mutation|August 19, 2006
Duplications in the DMD geneS J White, A Aartsma-Rus, K M Flanigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
A phase I study of topotecan followed sequentially by doxorubicin in patients with advanced malignanciesA W Tolcher, J A O'Shaughnessy, R B Weiss, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 24, 2001
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioningC L Cameron, D Cella, J E Herndon, et al.
American Journal of Medical Genetics. Part A|February 22, 2005
Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohortK M Dent, D M Dunn, A C von Niederhausern, et al.
Cancer|January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, L A Leone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B studyM Perloff, L Norton, A H Korzun, et al.
Journal of Medical Genetics|February 4, 2005
Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathyA K Lampe, D M Dunn, A C von Niederhausern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461J C Byrd, R B Weiss, D C Arthur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group BA B Kornblith, J E Herndon, E Zuckerman, et al.
Cancer|August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.
Pageof 25

Showing results (231-240 of 244) with videos related to

Sort By:
Pageof 25
Human Mutation|August 19, 2006
Duplications in the DMD geneS J White, A Aartsma-Rus, K M Flanigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
A phase I study of topotecan followed sequentially by doxorubicin in patients with advanced malignanciesA W Tolcher, J A O'Shaughnessy, R B Weiss, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 24, 2001
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioningC L Cameron, D Cella, J E Herndon, et al.
American Journal of Medical Genetics. Part A|February 22, 2005
Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohortK M Dent, D M Dunn, A C von Niederhausern, et al.
Cancer|January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, L A Leone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B studyM Perloff, L Norton, A H Korzun, et al.
Journal of Medical Genetics|February 4, 2005
Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathyA K Lampe, D M Dunn, A C von Niederhausern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461J C Byrd, R B Weiss, D C Arthur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group BA B Kornblith, J E Herndon, E Zuckerman, et al.
Cancer|August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.
Pageof 25